ArticleThe American journal of pathology2009

Modulation of the E2F1-driven cancer cell fate by the DNA damage response machinery and potential novel E2F1 targets in osteosarcomas.

Michalis Liontos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.